South African Company Nears License to Sell J. & J. Covid Shot Across Africa ![](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_vpYXTbyQsLGTWrbYCXx_4c1zFVdDyJzTVPVD0ACywHdsyZwD-moth6qFHXhPk1siB0197ZVptIZZS0jGsUz5Ib0TbutrIcrNcsVpGSbUDMcBhhEo8bNztstT_0YlgQeAwefwN07SgRkalf1FYzAU0YFrQuo4u7b0TeaYX_-GIj920l887z_ptQshMm5M3pgJbJ7mJqLk78nkQEzMs0LpnnGjmZ-7Q4=s0-d)
By Stephanie Nolen from NYT Health https://ift.tt/3D8Czev
Johnson & Johnson, Vaccination and Immunization, AFRICA, International Trade and World Market, Coronavirus (2019-nCoV), Drugs (Pharmaceuticals), Intellectual Property, South Africa, your-feed-science
By Stephanie Nolen from NYT Health https://ift.tt/3D8Czev
Johnson & Johnson, Vaccination and Immunization, AFRICA, International Trade and World Market, Coronavirus (2019-nCoV), Drugs (Pharmaceuticals), Intellectual Property, South Africa, your-feed-science
Comments
Post a Comment